Detailed Characterization of Neuroprotection by a Rescue Factor Humanin against Various Alzheimer's Disease-Relevant Insults
Open Access
- 1 December 2001
- journal article
- research article
- Published by Society for Neuroscience in Journal of Neuroscience
- Vol. 21 (23) , 9235-9245
- https://doi.org/10.1523/jneurosci.21-23-09235.2001
Abstract
A novel factor, termed Humanin (HN), antagonizes against neurotoxicity by various types of familial Alzheimer9s disease (AD) genes [V642I and K595N/M596L (NL) mutants of amyloid precursor protein (APP), M146L-presenilin (PS) 1, and N141I-PS2] and by Aβ1–43 with clear action specificity ineffective on neurotoxicity by polyglutamine repeat Q79 or superoxide dismutase 1 mutants. Here we report that HN can also inhibit neurotoxicity by other AD-relevant insults: other familial AD genes (A617G-APP, L648P-APP, A246E-PS1, L286V-PS1, C410Y-PS1, and H163R-PS1), APP stimulation by anti-APP antibody, and other Aβ peptides (Aβ1–42 and Aβ25–35). The action specificity was further indicated by the finding that HN could not suppress neurotoxicity by glutamate or prion fragment. Against the AD-relevant insults, essential roles of Cys8 and Ser14 were commonly indicated, and the domain from Pro3 to Pro19 was responsible for the rescue action of HN, in which seven residues turned out to be essential. We also compared the neuroprotective action of S14G HN (HNG) with that of activity-dependent neurotrophic factor, IGF-I, or basic FGF for the antagonism against various AD-relevant insults (V642I-APP, NL-APP, M146L-PS1, N141I-PS2, and Aβ1–43). Although all of these factors could abolish neurotoxicity by Aβ1–43, only HNG could abolish cytotoxicities by all of them. HN and HN derivative peptides may provide a new insight into the study of AD pathophysiology and allow new avenues for the development of therapeutic interventions for various forms of AD.Keywords
This publication has 43 references indexed in Scilit:
- Mechanisms of Neuroprotection by a Novel Rescue Factor Humanin from Swedish Mutant Amyloid Precursor ProteinBiochemical and Biophysical Research Communications, 2001
- Redox-active iron mediates amyloid-β toxicityFree Radical Biology & Medicine, 2001
- Multiple Mechanisms Underlie Neurotoxicity by Different Types of Alzheimer's Disease Mutations of Amyloid Precursor ProteinJournal of Biological Chemistry, 2000
- Novel Leu723Pro amyloid precursor protein mutation increases amyloid ?42(43) peptide levels and induces apoptosisAnnals of Neurology, 2000
- High Prevalence of Pathogenic Mutations in Patients with Early-Onset Dementia Detected by Sequence Analyses of Four Different GenesAmerican Journal of Human Genetics, 2000
- Involvement of Cell Cycle Elements, Cyclin-dependent Kinases, pRb, and E2F·DP, in B-amyloid-induced Neuronal DeathJournal of Biological Chemistry, 1999
- Functional cloning of genes involved in T-cell receptor-induced programmed cell deathSeminars in Immunology, 1997
- Suppression of Mitochondrial Succinate Dehydrogenase, a Primary Target of β‐Amyloid, and Its Derivative Racemized at Ser ResidueJournal of Neurochemistry, 1995
- Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: Evidence that an initially deposited species is Aβ42(43)Neuron, 1994
- Neurotrophic and Neurotoxic Effects of Amyloid β Protein: Reversal by Tachykinin NeuropeptidesScience, 1990